Search results
TEVA Q1 Earnings Miss, Schizophrenia Study Meets Goal, Stock Up
Zacks via Yahoo Finance· 4 days agoTEVA reports mixed first-quarter results, missing estimates for earnings but beating the same for...
What the Options Market Tells Us About Teva Pharmaceutical Indus - Teva Pharmaceutical Indus...
Benzinga· 1 hour agoBesides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory ...
Earnings call: Teva Pharmaceuticals reports growth and pipeline progress By Investing.com
Investing.com· 4 days agoFinancial highlights include a 5% revenue increase, a 12% rise in adjusted EBITDA, and an 18%...
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
Reuters via Yahoo Finance· 5 days agoTeva Pharmaceutical Industries said it was set to launch its long awaited biosimilar of AbbVie's...
Stocks making the biggest moves midday: Uber, Intel, Lyft, Shopify, Rivian and more
CNBC· 5 days agoThese are the stocks posting the largest moves in midday trading.
Teva stock gains on trial win, Q1 beat (NYSE:TEVA)
Seeking Alpha· 5 days agoTeva Pharmaceutical (TEVA) stock posts record gains due to better-than-expected Q1 revenue and positive Phase 3 trial results for its schizophrenia drug....
Teva Pharma's Turnaround Story: How A Key Win Helped It Clinch A Five-Year High
Investor's Business Daily· 5 days agoHighly Rated Pharma Stock Meanwhile, sales of its generic drugs rose more than 6% globally to $2.29...
An Expert Talks About New Research on Migraine Treatments
Healthline· 3 days agoNeurologist Dr. Susan Lee answers common questions about new treatments for migraine and where the...
Teva Pharma Gains on Q1 Revenue Beat
Investing.com· 6 days agoTeva Pharma Gains on Q1 Revenue Beat
Teva Pharm Q1 profit misses estimates, revenue risea
WHTC 1450 Holland· 5 days agoBy Steven Scheer JERUSALEM (Reuters) - Teva Pharmaceutical Industries reported a smaller than expected rise in first-quarter profit citing higher impairments of tangible assets, while sales ...